How do biotech companies use podcasts?
Biotech teams use podcasts to explain their science to investors, partners and future hires, and to give founders a public voice. Investor-led shows use them to meet founders and share how they think. The common thread is long, careful conversations about hard ideas that deserve a careful edit.
What rules apply to biotech and pharma podcasts?
If your company has an approved or investigational product, what you say about it on a podcast can count as promotion. In the US, the FDA's Office of Prescription Drug Promotion oversees prescription drug promotion, and companies may not promote investigational drugs as safe or effective.
Most companies route episodes and clips through medical, legal and regulatory (MLR) review. More detail: MLR review and FDA rules for pharma and biotech podcasts.
How do you make medical, legal and regulatory review easier?
We send a timestamped edit log and a transcript with every cut, so reviewers can check claims without watching the whole episode twice. Clips and trailers use verbatim lines only. If reviewers ask for a change, it lands on our timeline as a marker and comes back fast.
How do you explain complex science on screen?
When a guest names a mechanism, a target or a trial phase, a short plain-language definition appears at that moment. Numbers a guest cites can become simple charts, with the source shown. The guest keeps talking at their natural level, and a general viewer still follows.
Questions people ask
Do you work with investor and venture podcasts?
Yes. Investor-led shows that interview founders and scientists fit our process well: long, dense conversations that need careful edits, clips for LinkedIn and pages that explain the ideas.
Last updated 22 November 2026
CatalystX Media

